Microbiology & Infectious Diseases

Analysis of over 1.5 million U.S. adults in a new study has found that annual COVID-19 variant-targeted boosters provide meaningful protection against severe disease but lose effectiveness beyond 6 months.

A machine learning-based model has demonstrated the ability to predict active tuberculosis (TB) in people with HIV (PWH) using clinical data, offering a promising tool for improving early detection and preventive treatment.

New data from a 15-year study presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco reveals significant disparities in latent tuberculosis infection (LTBI) testing practices within the United States.

A recent study presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco has unveiled a simplified approach to assessing antiretroviral therapy (ART) adherence among pregnant women living with HIV in Malawi.

A new systematic review and meta-analysis of over 1.3 million patients has confirmed that remdesivir significantly improves survival rates for hospitalized COVID-19 patients, yet treatment guidelines may not fully reflect this evolving evidence.

Cytomegalovirus (CMV) plays a significant role in stillbirths and childhood deaths in low- and middle-income countries (LMICs), according to the results of a new study.

A state-of-the-art review emphasizes the critical role of data and trust in enhancing healthcare for transgender and gender-diverse (TGD) patients.

A recent global study found significant improvements in health-related quality of life (HQoL) among individuals with Hepatitis C (HCV) treated with direct-acting antivirals (DAAs) under a minimal monitoring (MINMON) approach.